Abstract
Transthyretin (TTR) amyloidosis is a form of systemic amyloidosis caused by an amyloidogenetic TTR variant. The most common mutant forms of TTR are mainly produced by the liver and therefore orthotopic liver transplantation (OLT) is currently accepted as the only known curative treatment. We describe the clinical and pathological features of a patient with TTR variant (gly53glu) with TTR amyloid infiltration of the leptomeningeal vessels in whom fatal cerebral haemorrhage occurred two months after OLT, soon after severe viral pneumonia.
Similar content being viewed by others
![](https://media.springernature.com/w215h120/springer-static/image/art%3A10.1007%2Fs42399-023-01418-y/MediaObjects/42399_2023_1418_Fig1_HTML.png)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
De Carolis, P., Galeotti, M., Ficarra, G. et al. Fatal cerebral haemorrhage after liver transplantation in a patient with transthyretin variant (gly53glu) amyloidosis. Neurol Sci 27, 352–354 (2006). https://doi.org/10.1007/s10072-006-0709-5
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10072-006-0709-5